National Taiwan University (NTU)

Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation (2020) Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WY, Koh LP, et al. Journal article Neutrino vertex reconstruction with in-ice radio detectors using surface reflections and implications for the neutrino energy resolution (2019) Anker A, Barwick SW, Bernhoff H, Besson DZ, Bingefors N, Garcia-Fernandez D, Gaswint G, et al. Journal article An electroactive alginate hydrogel nanocomposite reinforced by functionalized graphite nanofilaments for neural tissue engineering (2019) Homaeigohar S, Tsai TY, Young TH, Yang HJ, Ji YR Journal article Spin-order dependent anomalous Hall effect and magneto-optical effect in the noncollinear antiferromagnets Mn3X N with X=Ga, Zn, Ag, or Ni (2019) Zhou X, Hanke JP, Feng W, Li F, Guo GY, Yao Y, Bluegel S, Mokrousov Y Journal article sPlot – A new tool for global vegetation analyses (2019) Bruelheide H, Dengler J, Jiménez-Alfaro B, Purschke O, Hennekens SM, Chytrý M, Pillar VD, et al. Journal article Targeting ultra-high energy neutrinos with the ARIANNA experiment (2019) Anker A, Barwick SW, Bernhoff H, Besson DZ, Bingefors N, Gaswint G, Glaser C, et al. Journal article Observation of classically 'forbidden' electromagnetic wave propagation and implications for neutrino detection. (2018) Barwick SW, Berg EC, Besson DZ, Gaswint G, Glaser C, Hallgren A, Hanson JC, et al. Journal article Analysis of the influence of microRNAs in lithium response in bipolar disorder (2018) Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, et al. Journal article Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: A genome-wide association study (2018) Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, et al. Journal article Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial (2018) Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, et al. Journal article